Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology
Oral and maxillofacial pathologyDifferential impairment of vascularization and angiogenesis in bisphosphonate-associated osteonecrosis of the jaw-related mucoperiosteal tissue
Section snippets
Patients and material harvesting
This study included oral mucoperiosteal specimens from 40 patients. Of these, 20 specimens were from periodontal soft tissue adjacent to clinically and histologically confirmed BONJ of 20 consecutively treated patients undergoing radical sequestrectomy. Tissue specimens were taken as part of the tissue samples provided for routine histopathologic diagnostics. The necrotic tissue itself was excluded from the analysis. This study was approved by the local Ethical Committee of the University of
Results
Capillaries were seen in BONJ-related mucoperiosteal specimens and healthy jaw connective tissue. In normal jaw mucoperiosteal tissue and in BONJ-related samples, vascularization was clearly detectable by CD31-positive capillary staining in both groups (Figs. 1, A, and 2, A). No morphologic differences regarding the capillaries were seen between BONJ-affected and nonBP-exposed mucoperiosteal tissue. Vascular endothelial cell layers in both groups showed similar shapes and thicknesses. Newly
Discussion
These results show reduced angiogenesis in BONJ-related oral mucoperiosteal tissue compared with normal tissue, as shown by the significantly (P < .05) decreased CD105-positive relative capillary area. The inhibition of angiogenesis without significant effect on vascularization in BONJ was demonstrated for the first time in this study.
Reduced angiogenesis is consistent with the clinical finding of local dentoalveolar trauma-related incidence in BONJ and prolonged mucosal healing.26, 27 Whereas
References (41)
Osteonecrosis of the jaw: who gets it, and why?
Bone
(2009)- et al.
Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy
Bone
(2009) - et al.
Inhibition of oral mucosal cell wound healing by bisphosphonates
J Oral Maxillofac Surg
(2008) - et al.
Satellite cell proliferation, reinnervation, and revascularization in human free microvascular muscle flaps
J Surg Res
(2003) - et al.
Correlation between the arthroscopic diagnosis of synovitis and microvessel density in synovial tissues in patients with internal derangement of the temporomandibular joint
J Craniomaxillofac Surg
(2003) - et al.
Transforming growth factor beta 1 dependent regulation of tenascin-C in radiation impaired wound healing
Radiother Oncol
(2004) - et al.
Osteonecrosis of the jaw and the role of bisphosphonates: a critical review
Am J Med
(2009) - et al.
Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?
J Oral Maxillofac Surg
(2005) - et al.
Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment
J Oral Maxillofac Surg
(2008) - et al.
Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?
Bone
(2009)
Osteoclasts are important for bone angiogenesis
Blood
Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid
Transl Res
Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease
Eur J Cancer
Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology and Japanese Society of Oral and Maxillofacial Surgeons
J Bone Miner Metab
Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench
Cells Tissues Organs
Osteonecrosis of the jaws and bisphosphonate therapy
J Dent Res
Osteonecrosis of the jaws in patients treated with bisphosphonates—histomorphologic analysis in comparison with infected osteoradionecrosis
J Oral Pathol Med
Alendronate in the treatment of avascular necrosis of the hip
Rheumatology (Oxford)
The effect of zoledronate on bone remodeling during the healing process
Acta Cir Bras
Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair
J Bone Miner Res
Cited by (0)
Supported by the ELAN-Fonds of the University of Erlangen-Nuremberg.